Newsletter - January 21, 2021
New Administration = New FDA? Not So much
With a new administration comes a general perception that it will bring major changes at the FDA. But new administrations do not affect most of the operations of the FDA, at least not immediately, and certainly not for most of the regulated industry. The most visible changes are at the administrative levels with a new FDA commissioner...Read More
Oncology and Regenerative Medicine Products, and the Biden Administration
The oncology products and regenerative medicine products in development should see major positive changes with the new administration. The cancer moonshot that was announced near the end of the Obama administration, has not been in much news for the last 4 years. President Biden has a long history of championing ...Read More
New Administration = New FDA? Not So much
With a new administration comes a general perception that it will bring major changes at the FDA. But new administrations do not affect most of the operations of the FDA, at least not immediately, and certainly not for most of the regulated industry. The most visible changes are at the administrative levels with a new FDA commissioner...Read More
Oncology and Regenerative Medicine Products, and the Biden Administration
The oncology products and regenerative medicine products in development should see major positive changes with the new administration. The cancer moonshot that was announced near the end of the Obama administration, has not been in much news for the last 4 years. President Biden has a long history of championing ...Read More